OpGen Inc Performance
| OPGNDelisted Stock | USD 1.90 0.15 7.32% |
The company holds a Beta of -1.34, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning OpGen are expected to decrease by larger amounts. On the other hand, during market turmoil, OpGen is expected to outperform it. OpGen Inc right now holds a risk of 0.0%. Please check OpGen Inc value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if OpGen Inc will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days OpGen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, OpGen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 7.9 M |
OpGen |
OpGen Relative Risk vs. Return Landscape
If you would invest 190.00 in OpGen Inc on August 28, 2024 and sell it today you would earn a total of 0.00 from holding OpGen Inc or generate 0.0% return on investment over 90 days. OpGen Inc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than OpGen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OpGen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OpGen's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as OpGen Inc, and traders can use it to determine the average amount a OpGen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OPGN |
Based on monthly moving average OpGen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OpGen by adding OpGen to a well-diversified portfolio.
OpGen Fundamentals Growth
OpGen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of OpGen, and OpGen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OpGen Pink Sheet performance.
| Return On Equity | -3.15 | ||||
| Return On Asset | -0.52 | ||||
| Operating Margin | (10.13) % | ||||
| Current Valuation | 29.68 M | ||||
| Shares Outstanding | 8.36 M | ||||
| Price To Earning | (0.39) X | ||||
| Price To Book | 2.79 X | ||||
| Price To Sales | 6.13 X | ||||
| Revenue | 3.42 M | ||||
| EBITDA | (14.23 M) | ||||
| Cash And Equivalents | 10.28 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 13.04 M | ||||
| Debt To Equity | 1.11 % | ||||
| Book Value Per Share | (9.02) X | ||||
| Cash Flow From Operations | (14.32 M) | ||||
| Earnings Per Share | (40.32) X | ||||
| Total Asset | 1.88 M | ||||
| Retained Earnings | (305.49 M) | ||||
| Current Asset | 9.89 M | ||||
| Current Liabilities | 4.59 M | ||||
About OpGen Performance
By examining OpGen's fundamental ratios, stakeholders can obtain critical insights into OpGen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that OpGen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The company was incorporated in 2001 and is headquartered in Rockville, Maryland. Opgen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.Things to note about OpGen Inc performance evaluation
Checking the ongoing alerts about OpGen for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for OpGen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OpGen Inc is not yet fully synchronised with the market data | |
| OpGen Inc may become a speculative penny stock | |
| OpGen Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.42 M. Net Loss for the year was (32.67 M) with loss before overhead, payroll, taxes, and interest of (8.99 M). | |
| OpGen Inc currently holds about 10.28 M in cash with (14.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Latest headline from finance.yahoo.com: NVNO Completes Application for VenoValves PMA, Shares Likely to Gain |
- Analyzing OpGen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OpGen's stock is overvalued or undervalued compared to its peers.
- Examining OpGen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OpGen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OpGen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OpGen's pink sheet. These opinions can provide insight into OpGen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in OpGen Pink Sheet
If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |